Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug public-private partnerships

Wheeler, C. and S. Berkley. 2001. Initial Lessons from Public-Private Partnerships in Drug and Vaccine Development. Bulletin of the World Health Organization 1 i-. [Pg.56]

Nwaka S, Ridley RG (2003) Virtual drug discovery and development for neglected diseases through public-private partnerships. Nat Rev Drug Discov 2(ll) 919-928... [Pg.153]

Reichman, the TB expert from New Jersey, says he doesn t expect Big Pharma to jump in to find a cure for the disease he specializes in. People forget that drug companies are responsible to their shareholders. They re not responsible to mankind, he says. He puts his hopes in public-private partnerships that could bankroll small companies willing to develop new drugs. Others say the government will have to end up funding the research. [Pg.220]

Several public-private partnerships support development of drugs, vaccines, and diagnostics to address diseases that predominantly afflict the poor or to make drugs... [Pg.189]

The Foundation for the National Institutes of Health identifies and develops opportunities for innovative public-private partnerships involving industry, academia, and the philanthropic community (www.fnih.org). There were over 100 public-private partnerships funded with over 1 billion, with 60 active R D projects for vaccines and drugs for tropical and neglected diseases by the end of 2005 (Table 1.5-13). [Pg.190]

Flallock YF, Cragg GM. National Cooperative Drug Discovery Groups (NCDDGs) a successful model for public private partnerships in cancer drug discovery. Pharm Biol 2003 41(Suppl) 78-91. [Pg.45]

Gallagher, W.M., Tweats, D., and Koenig, J., Omic profiling for drug safety assessment Current trends and public-private partnerships. Drug Discov. Today, 14, 337, 2009. [Pg.494]

Advocates of end-to-end systems often argue that nonprofit firms are less able to pick and develop winning drug candidates than their private-sector counterparts. Since many Private-Public Partnerships hire executives directly from private industry, this cannot be a matter of individual competence. If the effect exists at all, it must be a matter of incentives. [Pg.102]


See other pages where Drug public-private partnerships is mentioned: [Pg.278]    [Pg.78]    [Pg.79]    [Pg.79]    [Pg.90]    [Pg.93]    [Pg.76]    [Pg.127]    [Pg.10]    [Pg.148]    [Pg.148]    [Pg.139]    [Pg.19]    [Pg.24]    [Pg.262]    [Pg.195]    [Pg.435]    [Pg.133]    [Pg.411]    [Pg.502]    [Pg.307]    [Pg.311]    [Pg.315]    [Pg.717]    [Pg.17]    [Pg.192]    [Pg.670]    [Pg.316]    [Pg.8]    [Pg.1383]    [Pg.171]    [Pg.102]    [Pg.103]    [Pg.105]    [Pg.50]    [Pg.171]    [Pg.17]    [Pg.110]    [Pg.178]   
See also in sourсe #XX -- [ Pg.717 ]




SEARCH



Partnership

Private

Privatization

Public-private

Public-private partnerships

© 2024 chempedia.info